Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Pharmacovigilance And Drug Safety Software Market Growth Performance Trended Historically, And What Lies Ahead?
The market size for pharmacovigilance and drug safety software has experienced a significant increase lately. The market forecast shows a rise from $2.26 billion in 2024 to $2.53 billion in 2025, representing a compound annual growth rate (CAGR) of 12.3%. Historically, the growth has been driven by a heightened demand for pharmacovigilance and drug safety software.
The market size of pharmacovigilance and drug safety software is projected to experience a significant surge in the coming years, with an expected growth up to $4.09 billion by 2029, reflecting a compound annual growth rate (CAGR) of 12.7%. This expansion during the forecast period is largely due to an upswing in adverse drug reaction cases and the worldwide spread of pharmacovigilance. Other contributing factors include a rise in adverse drug reactions, the growing intricacies in drug safety regulations, a surge in the creation of new drugs and therapies, and an increase in adverse drug reaction (ADR) incidents. In the forecast period, key trends to watch out for include the integration of automation and AI, cloud-based solutions, technological innovation, advancements in technologies, and a growing trend towards healthcare digitalization.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19140&type=smp
What Are the Core Market Drivers Propelling Growth in the Pharmacovigilance And Drug Safety Software Industry?
The expansion of the pharmacovigilance and drug safety software market is projected to be fuelled by the increasing need for personalized or precision medicine. This particular medical practice, which customizes healthcare choices and therapies based on each patient’s specifics, is gaining popularity due to factors like enhanced treatment results, emphasis on prevention and early diagnosis, and affordability. Pharmacovigilance and drug safety software play an essential role within personalized medicine, their key contributions being pharmacogenetics, real-time data analysis, post-marketing surveillance, and tailored medication information, all contributing towards more secure and effective individual therapies, efficient risk management, and handling ethical considerations. The Personalized Medicine Coalition, a non-profit organization based in the US, recorded in February 2024 that the FDA had granted approval to 16 new personalized therapies in 2023 for patients with uncommon diseases, a considerable jump from just 6 in 2022. This surge in demand for personalized medicine is, therefore, a significant driver for the pharmacovigilance and drug safety software market’s growth.
How Is the Pharmacovigilance And Drug Safety Software Market Segmented?
The pharmacovigilance and drug safety software market covered in this report is segmented –
1) By Software Type: Adverse Event Reporting Software, Drug Safety Audits Software, Issue Tracking Software, Fully Integrated Software
2) By Delivery Mode: On-premise, Cloud-based
3) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Business Process Outsourcing Firms, Other End Users
Subsegments:
1) By Adverse Event Reporting Software: Spontaneous Reporting Systems, EHR Integration Solutions, Mobile Reporting Applications
2) By Drug Safety Audits Software: Audit Management Solutions, Compliance Tracking Tools, Reporting And Analytics Modules
3) By Issue Tracking Software: Incident Reporting Systems, Workflow Management Tools, Collaboration Platforms
4) By Fully Integrated Software: Pharmacovigilance Platforms, Regulatory Compliance Systems, Data Analytics And Visualization Tools
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=19140&type=smp
Which Regions Are Driving the Next Phase of the Pharmacovigilance And Drug Safety Software Market Growth?
North America was the largest region in the pharmacovigilance and drug safety software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacovigilance and drug safety software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Pharmacovigilance And Drug Safety Software Industry?
Leading businesses in the pharmacovigilance and drug safety software market are focusing on creating cutting-edge technologies, such as cloud-based data lake platforms. This innovation aims to boost patient safety, effectively monitor adverse incidents, and enhance regulatory adherence in clinical studies and post-market medical device monitoring. Cloud-based data lake platforms, centrally scalable storage systems, enable organizations to store, manage, and examine large volumes of both structured and unstructured data. It also provides instantaneous data access and supports advanced analytical and AI/ML workloads. For example, in December 2023, Thermo Fisher Scientific Inc., a biotech firm from the United States, introduced CorEvidence, a novel, proprietary cloud-based data lake platform developed to improve pharmacovigilance protocols in clinical research registries. The platform’s objective is to streamline case processing and safety data handling, particularly in post-authorization safety investigations.
View the full report here:
How Is the Pharmacovigilance And Drug Safety Software Market Defined and What Are Its Core Parameters?
Pharmacovigilance and drug safety software refers to a suite of digital tools designed to monitor, analyze, and report adverse drug reactions (ADRs) and other safety-related information associated with pharmaceuticals and medical products. This software plays a critical role in ensuring patient safety and regulatory compliance throughout the lifecycle of a drug, from development to post-marketing surveillance.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19140
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model